Announced
Completed
Financials
Sources
Tags
Acquisition
Cross Border
Spain
Private
health care
Majority
biotechnology
Private Equity
Completed
Friendly
Biotechnology
Auction
Synopsis
KKR, a private equity firm, completed the acquisition of IVI-RMA, a biotechnology company, for $3bn. IVI-RMA is a clinic that specializes in human reproduction, developing reproductive medicine. It was formed in 2017 when a group of doctors and investors from Spain’s eastern region of Valencia merged IVI with US rival RMANJ. The firm manages more than 75 clinics and 28 labs in nine countries.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.